These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 17004920)

  • 1. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin facilitates glycinergic and GABAergic synaptic transmission in developing hypoglossal motoneurons.
    Reymond-Marron I; Raggenbass M; Zaninetti M
    Eur J Neurosci; 2005 Mar; 21(6):1601-9. PubMed ID: 15845087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin and vasopressin enhance synaptic transmission in the hypoglossal motor nucleus of young rats by acting on distinct receptor types.
    Wrobel LJ; Reymond-Marron I; Dupré A; Raggenbass M
    Neuroscience; 2010 Feb; 165(3):723-35. PubMed ID: 19896520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory action of vasopressin in the brain of the rat: role of cAMP signaling.
    Wrobel LJ; Dupré A; Raggenbass M
    Neuroscience; 2011 Jan; 172():177-86. PubMed ID: 20933582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate triggers neonatal rat hypoglossal motoneurons in vitro to express rhythmic bursting with unusual Mg2+ sensitivity.
    Sharifullina E; Ostroumov K; Grandolfo M; Nistri A
    Neuroscience; 2008 Jun; 154(2):804-20. PubMed ID: 18468805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
    Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R
    J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic modulation of intracellular calcium dynamics in neonatal hypoglossal motoneurons from mouse.
    Ladewig T; Lalley PM; Keller BU
    Brain Res; 2004 Mar; 1001(1-2):1-12. PubMed ID: 14972649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals.
    Serradeil-Le Gal C; Derick S; Brossard G; Manning M; Simiand J; Gaillard R; Griebel G; Guillon G
    Stress; 2003 Sep; 6(3):199-206. PubMed ID: 13129813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identified motoneurons involved in sexual and eliminative functions in the rat are powerfully excited by vasopressin and tachykinins.
    Ogier R; Tribollet E; Suarez P; Raggenbass M
    J Neurosci; 2006 Oct; 26(42):10717-26. PubMed ID: 17050711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
    Perdonà E; Arban R; Griffante C
    Eur J Pharmacol; 2012 Mar; 679(1-3):16-23. PubMed ID: 22285855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin stimulates ciliary motility of rabbit tracheal epithelium: role of V1b receptor-mediated Ca2+ mobilization.
    Tamaoki J; Kondo M; Takeuchi S; Takemura H; Nagai A
    Am J Respir Cell Mol Biol; 1998 Aug; 19(2):293-9. PubMed ID: 9698602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-delimited G protein-mediated coupling between V1a vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells.
    Grazzini E; Durroux T; Payet MD; Bilodeau L; Gallo-Payet N; Guillon G
    Mol Pharmacol; 1996 Nov; 50(5):1273-83. PubMed ID: 8913359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.